In the BioHarmony Drug Report Database

"Preview" Icon

Lomustine

Gleostine (lomustine) is a small molecule pharmaceutical. Lomustine was first approved as Gleostine on 1982-01-01. It is used to treat brain neoplasms, colonic neoplasms, hodgkin disease, kidney neoplasms, and lung neoplasms amongst others in the USA.

 

Trade Name

 

Gleostine
 

Common Name

 

lomustine
 

ChEMBL ID

 

CHEMBL514
 

Indication

 

brain neoplasms, colonic neoplasms, hodgkin disease, kidney neoplasms, lung neoplasms, melanoma, non-hodgkin lymphoma
 

Drug Class

 

Antineoplastics (chloroethylamine derivatives)

Image (chem structure or protein)

Lomustine structure rendering